Evidence map›Paper›PMID 27789343›Full record

ArticleBehavioural brain research2017

Mitigating effect of EUK-207 on radiation-induced cognitive impairments.

J Raber, M J Davis, T Pfankuch, R Rosenthal, S R Doctrow, J E Moulder

Abstract read
In one paragraph

Article in Behavioural brain research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Effects of radiotherapy on the hippocampus and hippocampal neurogenesis: a systematic review of preclinical studies.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Pooled it
  2. Radiomitigators: Breakthroughs in Post-Radiation Recovery.Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Balanced Duality: HInternational journal of molecular sciences · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

J RaberDepartment of Behavioral Neuroscience, L470, Oregon Health and Science University, Portland, OR 97239, USA; Departments of Neurology and Radiation Medicine, Division of Neuroscience, ONPRC, L470, Oregon Health and Science University, Portland, Oregon 97239, USA. Electronic address: raberj@ohsu.edu.
M J DavisDepartment of Behavioral Neuroscience, L470, Oregon Health and Science University, Portland, OR 97239, USA.
T PfankuchDepartment of Behavioral Neuroscience, L470, Oregon Health and Science University, Portland, OR 97239, USA.
R RosenthalPulmonary Center, Boston University School of Medicine, MA 02215, USA.
S R DoctrowPulmonary Center, Boston University School of Medicine, MA 02215, USA.
J E MoulderDepartment of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Oregon Health & Science University · USBoston University · USMedical College of Wisconsin · US

Funding

Training and educationU19AI067734 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI OTTERSON, MARY F. · 2005 to 2009
$18.2M
NIAID NIH HHS U19 AI067734
6 · The paper itself

Abstract

The brain could be exposed to irradiation as part of a nuclear accident, radiological terrorism (dirty bomb scenario) or a medical radiological procedure. In the context of accidents or terrorism, there is considerable interest in compounds that can mitigate radiation-induced injury when treatment is initiated a day or more after the radiation exposure. As it will be challenging to determine the radiation exposure an individual has received within a relatively short time frame, it is also critical that the mitigating agent does not negatively affect individuals, including emergency workers, who might be treated, but who were not exposed. Alterations in hippocampus-dependent cognition often characterize radiation-induced cognitive injury. The catalytic ROS scavenger EUK-207 is a member of the class of metal-containing salen manganese (Mn) complexes that suppress oxidative stress, including in the mitochondria, and have been shown to mitigate radiation dermatitis, promote wound healing in irradiated skin, and mitigate vascular injuries in irradiated lungs. As the effects of EUK-207 against radiation injury in the brain are not known, we assessed the effects of EUK-207 on sham-irradiated animals and the ability of EUK-207 to mitigate radiation-induced cognitive injury. The day following irradiation or sham-irradiation, the mice started to receive EUK-207 and were cognitively tested 3 months following exposure. Mice irradiated at a dose of 15Gy showed cognitive impairments in the water maze probe trial. EUK-207 mitigated these impairments while not affecting cognitive performance of sham-irradiated mice in the water maze probe trial. Thus, EUK-207 has attractive properties and should be considered an ideal candidate to mitigate radiation-induced cognitive injury.

Indexed as

Analysis of VarianceAnimalsCognition DisordersConditioning, PsychologicalDose-Response Relationship, RadiationFearMaleMaze LearningMiceMice, Inbred C57BLOrganometallic CompoundsRadiation Injuries, ExperimentalSuperoxide DismutaseTyrosine3-nitrotyrosineEUK 207Organometallic CompoundsSuperoxide DismutaseTyrosine

Identifiers

PMID27789343
PMCPMC5239742
OpenAlexW2539173546

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.